Selvita S.A. (WSE:SLV)
25.00
-0.40 (-1.57%)
Jul 24, 2026, 5:00 PM CET
Selvita Revenue
Selvita had revenue of 79.99M PLN in the quarter ending March 31, 2026, a decrease of -12.28%. This brings the company's revenue in the last twelve months to 359.37M, down -0.12% year-over-year. In the year 2025, Selvita had annual revenue of 370.57M with 7.17% growth.
Revenue (ttm)
359.37M
Revenue Growth
-0.12%
P/S Ratio
1.28
Revenue / Employee
399.75K
Employees
899
Market Cap
458.89M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 370.57M | 24.80M | 7.17% |
| Dec 31, 2024 | 345.76M | -6.09M | -1.73% |
| Dec 31, 2023 | 351.85M | -12.70M | -3.48% |
| Dec 31, 2022 | 364.55M | 48.83M | 15.47% |
| Dec 31, 2021 | 315.73M | 173.80M | 122.46% |
| Dec 31, 2020 | 141.93M | -104.34B | -99.86% |
| Dec 31, 2019 | 104.48B | 21.42B | 25.78% |
| Dec 31, 2018 | 83.06B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.51B |
| Centrum Medyczne ENEL-MED | 885.29M |
| Synektik Spólka Akcyjna | 794.94M |
| Voxel | 583.14M |
| Mercator Medical | 572.42M |
| Ryvu Therapeutics | 88.38M |
| Captor Therapeutics Spolka Akcyjna | 2.38M |
Selvita News
- 2 months ago - Selvita Quarterly report: Q1 2026 - Filings
- 2 months ago - Selvita Slides: Q1 2026 - Filings
- 4 months ago - Selvita Annual report: Q4 2025 - Filings
- 4 months ago - Selvita Slides: Q4 2025 - Filings
- 8 months ago - Selvita Quarterly report: Q3 2025 - Filings
- 8 months ago - Selvita Slides: Q3 2025 - Filings
- 11 months ago - Selvita Quarterly report: Q2 2025 - Filings